glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - bältros (herpes zoster) - vacciner - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. användning av shingrix bör ske i enlighet med officiella rekommendationer.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)